Michael F. Huang, Senior VP of Clinical Development at SOLENO THERAPEUTICS INC (SLNO), sold 17,961 shares at $67.70 ($1.2M) on 2025-03-27, disclosed to the SEC on 2025-03-31.
Open-market sale of $1.2M SLNO by Senior VP of Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.97 | 371 | $24K | 2.0% |
| 2 | $66.79 | 604 | $40K | 3.2% |
| 3 | $67.70 | 1,098 | $74K | 6.0% |
| 4 | $67.70 | 1,098 | $74K | 6.0% |
| 5 | $68.79 | 1,444 | $99K | 8.0% |
| 6 | $68.79 | 1,444 |
| $99K |
| 8.0% |
| 7 | $69.84 | 836 | $58K | 4.7% |
| 8 | $69.84 | 836 | $58K | 4.7% |
| 9 | $70.03 | 10,000 | $700K | 56.2% |
| 10 | $70.73 | 86 | $6K | 0.5% |
| 11 | $71.74 | 125 | $9K | 0.7% |
| 12 | $72.64 | 19 | $1K | 0.1% |
| Total | $69.35 avg | 17,961 | $1.2M | 100% |